This evidence indicates that NXN contributes to obesity control (Figure 4) by acting as a proadipogenic factor, placing NXN as an attractive therapeutic target in obesity and metabolic disorders such as DM. The gene discussed is NXN; the disease is obesity due to melanocortin 4 receptor deficiency.